Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

Bristol-Myers Squibb

BMS establishes cancer vaccine network

June 1, 2012 Research and Development, Sales and Marketing

Bristol-Myers Squibb has formed a network of ten institutions to advance work on using the body’s own immune system to …
News

ROCK medical communications appoints two new account managers

June 1, 2012 Medical Communications, Research and Development, Sales and Marketing ROCK, medical communications, pharma appointment

ROCK medical communications has appointed two new team members: Suzanne Smith and Nicola Wood. Suzanne joins from Chameleon Communications, where …
Appointment

Boehringer appoints new executive director of Consumer Healthcare Marketing

May 31, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim

Boehringer Ingelheim has announced the appointment of Ross Ullman as the executive director marketing of the Consumer Healthcare division.  In …
Appointment

Vertex admits blunder over drug data

May 31, 2012 Sales and Marketing Kalydeco, Kalydeco., Vertex, cystic fibrosis

Vertex has been embarrassed after it released claims for its pipeline drug VX-809 which turned out to be incorrect. The …
News
human genome sciences

HGS shareholder challenges ‘poison pill’

May 31, 2012 Sales and Marketing Benlysta, GSK, HGS, hostile bid

The saga of GlaxoSmithKline’s attempt to take over Human Genome Sciences (HGS) has taken another turn with legal action by …
News

Pharma relieved as Senate backs FDA fees

May 30, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing FDA, PDUFA, PhRMA, US

The US Senate has approved a law that will continue to allow pharma firms to help fund the FDA.  The …
News

GSK starts combination trial for melanoma

May 30, 2012 Research and Development, Sales and Marketing GSK, R&D, Roche, Zelboraf, melanoma

GlaxoSmithKline has begun a combination trial for two of its investigational skin cancer drugs.  The firm will combine dabrafenib, its …
News

UK Prix Galien shortlist announced

May 30, 2012 Business Services, Medical Communications, Research and Development, Sales and Marketing Bayer, Janssen, Xarelto, awards, prix galien

The UK award for the most innovative new drug has been moved a step closer with the release of a …
News
brian_jolly_at_onyx_scientific_

Onyx appoints Brian Jolly to commercial team

May 30, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing CMO, Onyx, manufacturing

Onyx Scientific the chemistry and manufacturing specialist has bolstered its business development team with the appointment of a new director. …
Appointment

Landmark CF treatment set for European approval

May 30, 2012 Sales and Marketing CHMP, Europe, Kalydeco, Vertex, cystic fibrosis

A European committee is recommending the approval of Vertex’s first-in-class treatment for cystic fibrosis.  Kalydeco (ivacaftor) is a landmark in …
News

Sanofi/Regeneron cholesterol drug reaches Phase III

May 29, 2012 Research and Development, Sales and Marketing Amgen, PCKS9, Regeneron, SAR236553, Sanofi

Sanofi and Regeneron’s anti-cholesterol drug has impressed in a mid-stage trial, and will now progress into Phase III.  The firms’ …
News

Lundbeck’s Alzheimer’s drug shows promise

May 29, 2012 Research and Development, Sales and Marketing Alzheimer's, Lundbeck

Lundbeck’s Alzheimer’s candidate Lu AE58054 has shown signs in a phase II study of helping patients’ mental activity. Sufferers receiving …
News
Pradaxa image

European OK for Pradaxa, but more details required

May 29, 2012 Research and Development, Sales and Marketing Boehringer, CHMP, EMA, Europe, Pradaxa

The European Medicines Agency says that Boehringher’s Pradaxa can stay on the market, but will need more safety information.  The …
News

Cancer Drugs Fund ‘the wrong choice’ for Wales

May 29, 2012 Sales and Marketing CDF, Cancer, NHS, Wales, Welsh

The Welsh health minister Lesley Griffiths has said that a Cancer Drugs Fund is ‘not the right course’ for Wales. …
News

Recommendations for two Eisai epilepsy drugs

May 28, 2012 Sales and Marketing CHMP, Eisai, Zonegra, epilepsy

European regulators are likely to approve two of Eisai’s epilepsy drugs after advisers recommended both of them.First-in-class Fycompa (perampanel) has …
News
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 5, 2026

Phase 2 study explores imaging approach for interstitial lung disease

June 5, 2026

Laverock secures funding for gene-control platform development

June 4, 2026

LifeArc and Elpida partner to advance gene therapies for ultra-rare childhood diseases

June 3, 2026

Well Pharmacy and Alzheimer’s Society launch dementia partnership

June 2, 2026